The invention provides a composition for use in a method for treating one or more complications of diabetes in a mammal in need thereof, the composition comprising an effective amount of the peptide D-Arg-2'6'-Dmt-Lys-Phe-NH 2 or Phe-D-Arg-Phe-Lys-NH 2 .